Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul 3:15:1410066.
doi: 10.3389/fendo.2024.1410066. eCollection 2024.

Transcriptome analysis combined with Mendelian randomization screening for biomarkers causally associated with diabetic retinopathy

Affiliations

Transcriptome analysis combined with Mendelian randomization screening for biomarkers causally associated with diabetic retinopathy

Junyi Liu et al. Front Endocrinol (Lausanne). .

Abstract

Background: Diabetic retinopathy (DR) is considered one of the most severe complications of diabetes mellitus, but its pathogenesis is still unclear. We hypothesize that certain genes exert a pivotal influence on the progression of DR. This study explored biomarkers for the diagnosis and treatment of DR through bioinformatics analysis.

Methods: Within the GSE221521 and GSE189005 datasets, candidate genes were acquired from intersections of genes obtained using WGCNA and DESeq2 packages. Mendelian randomization (MR) analysis selected candidate biomarkers exhibiting causal relationships with DR. Receiver Operating Characteristic (ROC) analysis determined the diagnostic efficacy of biomarkers, the expression levels of biomarkers were verified in the GSE221521 and GSE189005 datasets, and a nomogram for diagnosing DR was constructed. Enrichment analysis delineated the roles and pathways associated with the biomarkers. Immune infiltration analysis analyzed the differences in immune cells between DR and control groups. The miRNet and networkanalyst databases were then used to predict the transcription factors (TFs) and miRNAs, respectively, of biomarkers. Finally, RT-qPCR was used to verify the expression of the biomarkers in vitro.

Results: MR analysis identified 13 candidate biomarkers that had causal relationships with DR. The ROC curve demonstrated favorable diagnostic performance of three biomarkers (OSER1, HIPK2, and DDRGK1) for DR, and their expression trends were consistent across GSE221521 and GSE189005 datasets. The calibration curves and ROC curves indicated good predictive performance of the nomogram. The biomarkers were enriched in pathways of immune, cancer, amino acid metabolism, and oxidative phosphorylation. Ten immune cell lines showed notable disparities between the DR and control groups. Among them, effector memory CD8+ T cells, plasmacytoid dendritic cells, and activated CD4+ T cells exhibited good correlation with biomarker expression. The TF-mRNA-miRNA network suggested that hsa-mir-92a-3p, GATA2, and RELA play important roles in biomarker targeting for DR. RT-qPCR results also demonstrated a notably high expression of HIPK2 in patients with DR, whereas notably low expression of OSER1.

Conclusion: OSER1, HIPK2, and DDRGK1 were identified as biomarkers for DR. The study findings provide novel insights into the pathogenesis of DR.

Keywords: Mendelian randomization; diabetic retinopathy; enrichment analysis; immune infiltration; regulatory network.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The flowchart of entire analysis process.
Figure 2
Figure 2
Acquisition of candidate genes (A) Volcano map of DR-DEGs (B) Heat map of DR-DEGs (C-F) WGCNA (C) Sample clustering diagram (D) The selection of soft threshold β (E) Module clustering diagram (F) the relevance heat map of gene modules and DR (G) Venn map of candidate genes.
Figure 3
Figure 3
Functional enrichment analysis and PPI network (A) GO functions enriched by candidate genes (B) KEGG pathways enriched by candidate genes (C) Disease enriched by candidate genes (D) PPI network of candidate gene.
Figure 4
Figure 4
Identification and validation of biomarkers (A–F) ROC curve analysis of candidate biomarkers in GSE221521 and GSE189005 datasets (G, H) The expression levels of OSER1, DDRGK1 and HIPK2 in GSE221521 and GSE189005 datasets (I–K) The expression levels of OSER1, DDRGK1 and HIPK2 in clinical samples by RT-qPCR. *: p < 0.5, ***: p < 0.001, ns: not statistically significant.
Figure 5
Figure 5
Construction and evaluation of the nomogram (A) Construction of the nomogram (B) Calibration curve of nomogram (C) ROC curve of nomogram.
Figure 6
Figure 6
GSEA and GSVA analysis of biomarkers (A-C) GSEA analysis of DDRGK1, HIPK2, and OSER1 (D-F) GSVA analysis of DDRGK1, HIPK2, and OSER1.
Figure 7
Figure 7
Immune infiltration analysis (A) Heat map of the distributions of the 28 immune cells (B) Differences in the abundance of immune cells in DR and Control groups (C) Differential immune cell correlation heat map (* represents the P-value < 0.05, the number represents the correlation coefficient) (D-F) Lollipop chart analysis of correlation between DDRGK1, HIPK2, and OSER1 with differential immune cells (The size of the circle represents correlation, and different colors represent different P-values). *: p < 0.5, **: p < 0.1, ***: p < 0.001, ns, not statistically significant.
Figure 8
Figure 8
TF-mRNA-miRNA regulatory network (Green represents TF, red represents biomarkers, and purple represents miRNA).

Similar articles

Cited by

References

    1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. (2010) 376:124–36. doi: 10.1016/S0140-6736(09)62124-3 - DOI - PubMed
    1. Teo ZL, Tham Y-C, Yu M, Chee ML, Rim TH, Cheung N, et al. . Global prevalence of diabetic retinopathy and projection of burden through 2045. Ophthalmology. (2021) 128:1580–91. doi: 10.1016/j.ophtha.2021.04.027 - DOI - PubMed
    1. Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, Boyle JP. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005–2050. Arch Ophthalmol. (2008) 126:1740–7. doi: 10.1001/archopht.126.12.1740 - DOI - PubMed
    1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. . IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. (2022) 183. doi: 10.1016/j.diabres.2021.109119 - DOI - PMC - PubMed
    1. Cai S, Liu TYA. The role of ultra-widefield fundus imaging and fluorescein angiography in diagnosis and treatment of diabetic retinopathy. Curr Diabetes Rep. (2021) 21:30. doi: 10.1007/s11892-021-01398-0 - DOI - PubMed